Data from our small cohort of gastric cancer patients show that HMGB1 levels were correlated with primary tumor progression and distant metastasis, whereas CML-HMGB1 levels were correlated with primary tumor progression, lymph node metastasis, distant metastasis, and stage. The gene discussed is HMGB1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.